CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
zinc sulphate dietary supplement +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00109551
NCT00109551Phase 3Completed
CompareCT.gov

Zinc Supplementation Impact on Child Mortality--Nepal

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)·interventional·Posted Apr 29, 2005·Updated May 1, 2013

In Brief

A Phase 3 clinical trial evaluating zinc sulphate dietary supplement and iron sulphate-folic acid dietary supplement for Nutrition. Completed, across 3 sites in 2 countries.

Detailed Summary

The purpose of this study is to determine whether daily supplementation of young children in Nepal with either zinc, iron-folic acid, or both can reduce mortality and morbidity. Young children in Nepal have numerous nutritional deficiencies and high rates of morbidity and mortality. Zinc and/or iron supplementation may be a cost-effective method for reducing these risks.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNutrition
CountriesNepal, United States
CollaboratorsUnited States Agency for International Development (USAID), Bill and Melinda Gates Foundation

Timeline

Phase 3CompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 29, 2005
Enrollment StartOct 1, 2001
Study CompletionJan 1, 2006
TodayJul 2, 2026
Posted 21.2 years ago

Interventions

zinc sulphate dietary supplementdrug

iron sulphate-folic acid dietary supplementdrug